Clinical trial
Prospective, Randomized Controlled Trial Comparing Amoxicillin and Metronidazole Based Bismuth-containing Quadruple Therapy With Amoxicillin and Clarithromycin Based Quadruple Therapy for First-line Helicobacter Pylori Eradication
NCT02175901 is registered in ClinicalTrials.gov with Shanghai Jiao Tong University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Randomized Controlled Trial Comparing Amoxicillin and Metronidazole Based Bismuth-containing Quadruple Therapy With Amoxicillin and Clarithromycin Based Quadruple Therapy for First-line Helicobacter Pylori Eradication
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- January 31, 2015
- Enrollment
- 215 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.